Eureka Nanobioengineering is a brand with a mission to create innovative and cost-effective next-generation nanobiodevices and advanced functional nanobiomaterials. Inspired by the wonders of nature and utilizing cutting-edge nano- and bio-technological tools, our team of experts in chemistry, biophysics, nanoscience, and biomedicine is dedicated to making customizable and personalized solutions accessible to the mass market.

Currently, we are focused on developing a diverse range of applications within our in-house portfolio, including vaccine platforms and novel biocatalysts. Additionally, we are actively seeking partnership opportunities to co-develop solutions that span multiple scientific and technological fields.

Our talented team, led by founders Damián Alvarez Paggi, Daniel Murgida, Salvador Ventura, and Hugo Menzella, offers a wealth of expertise. We are also fortunate to have esteemed advisors Fernando Polack, Adnan Custovic, Mauricio Caballero, and Pablo Torti, as well as the support of Analía Boudgouste, Carla Goldin, Alana Byrne, Sebastián Esperante, and Virginia Tribulatti.

At Eureka Nanobioengineering, we are committed to advancing innovation and making a positive impact in various industries. Contact us at [email protected] for more information. We look forward to connecting with you.